BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1454064)

  • 1. Expression of the V(D)J recombinase gene RAG-1 is tightly regulated and involves both transcriptional and post-transcriptional controls.
    Neale GA; Fitzgerald TJ; Goorha RM
    Mol Immunol; 1992 Dec; 29(12):1457-66. PubMed ID: 1454064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAG-1 and RAG-2 gene expression and V(D)J recombinase activity are enhanced by protein phosphatase 1 and 2A inhibition in lymphocyte cell lines.
    Casillas AM; Thompson AD; Cheshier S; Hernandez S; Aguilera RJ
    Mol Immunol; 1995 Feb; 32(3):167-75. PubMed ID: 7898493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A V(D)J recombinase-inducible B-cell line: role of transcriptional enhancer elements in directing V(D)J recombination.
    Oltz EM; Alt FW; Lin WC; Chen J; Taccioli G; Desiderio S; Rathbun G
    Mol Cell Biol; 1993 Oct; 13(10):6223-30. PubMed ID: 8413222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination.
    Oettinger MA; Schatz DG; Gorka C; Baltimore D
    Science; 1990 Jun; 248(4962):1517-23. PubMed ID: 2360047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymocyte expression of RAG-1 and RAG-2: termination by T cell receptor cross-linking.
    Turka LA; Schatz DG; Oettinger MA; Chun JJ; Gorka C; Lee K; McCormack WT; Thompson CB
    Science; 1991 Aug; 253(5021):778-81. PubMed ID: 1831564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function and control of recombination-activating gene activity.
    Alt FW; Rathbun G; Oltz E; Taccioli G; Shinkai Y
    Ann N Y Acad Sci; 1992 May; 651():277-94. PubMed ID: 1599127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two waves of recombinase gene expression in developing thymocytes.
    Wilson A; Held W; MacDonald HR
    J Exp Med; 1994 Apr; 179(4):1355-60. PubMed ID: 8145048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin gene hypermutation in germinal centers is independent of the RAG-1 V(D)J recombinase.
    Zheng B; Han S; Spanopoulou E; Kelsoe G
    Immunol Rev; 1998 Apr; 162():133-41. PubMed ID: 9602359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional and post-transcriptional regulation of c-jun expression during monocytic differentiation of human myeloid leukemic cells.
    Sherman ML; Stone RM; Datta R; Bernstein SH; Kufe DW
    J Biol Chem; 1990 Feb; 265(6):3320-3. PubMed ID: 2105946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 mRNA levels and degradation rates change with mode of stimulation and phorbol ester treatment of lymphocytes.
    Bill O; Garlisi CG; Grove DS; Holt GE; Mastro AM
    Cytokine; 1994 Jan; 6(1):102-10. PubMed ID: 8003628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The V(D)J recombination activating gene, RAG-1.
    Schatz DG; Oettinger MA; Baltimore D
    Cell; 1989 Dec; 59(6):1035-48. PubMed ID: 2598259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phorbol ester exposure activates an AP-1-mediated increase in ERCC-1 messenger RNA expression in human ovarian tumor cells.
    Li Q; Zhang L; Tsang B; Gardner K; Bostick-Bruton F; Reed E
    Cell Mol Life Sci; 1999 Mar; 55(3):456-66. PubMed ID: 10228559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DDE motif in RAG-1 is contributed in trans to a single active site that catalyzes the nicking and transesterification steps of V(D)J recombination.
    Swanson PC
    Mol Cell Biol; 2001 Jan; 21(2):449-58. PubMed ID: 11134333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paleo-immunology: evidence consistent with insertion of a primordial herpes virus-like element in the origins of acquired immunity.
    Dreyfus DH
    PLoS One; 2009 Jun; 4(6):e5778. PubMed ID: 19492059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered topoisomerase I activity and recombination activating gene expression in a human leukemia cell line resistant to doxorubicin.
    Riou JF; Grondard L; Petitgenet O; Abitbol M; Lavelle F
    Biochem Pharmacol; 1993 Sep; 46(5):851-61. PubMed ID: 8396937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of IL-7 V(D)J recombination.
    Döbbeling U
    Immunology; 1996 Dec; 89(4):569-72. PubMed ID: 9014823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transcriptional regulation of granulocyte-macrophage colony-stimulating factor synthesis in murine T cells.
    Bickel M; Cohen RB; Pluznik DH
    J Immunol; 1990 Aug; 145(3):840-5. PubMed ID: 2197329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rch1, a protein that specifically interacts with the RAG-1 recombination-activating protein.
    Cuomo CA; Kirch SA; Gyuris J; Brent R; Oettinger MA
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6156-60. PubMed ID: 8016130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13-acetate.
    Saceda M; Knabbe C; Dickson RB; Lippman ME; Bronzert D; Lindsey RK; Gottardis MM; Martin MB
    J Biol Chem; 1991 Sep; 266(27):17809-14. PubMed ID: 1917923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional modulation of the human complement factor I gene in Hep G2 cells by protein kinase C activation.
    Minta J; Fung M
    Mol Cell Biochem; 1999 Nov; 201(1-2):111-23. PubMed ID: 10630630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.